BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29287589)

  • 1. Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.
    Yamagata A; Uchida T; Yamada Y; Nakanishi T; Nagai K; Imakiire T; Oshima N; Kumagai H
    BMC Nephrol; 2017 Dec; 18(1):377. PubMed ID: 29287589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.
    Giannese D; Ferro F; Moriconi D; Bonadio AG; Elefante E; Egidi MF; Cupisti A; Baldini C
    CEN Case Rep; 2021 Feb; 10(1):23-29. PubMed ID: 32681397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.
    Fukuda M; Sawa N; Hoshino J; Ohashi K; Motoaki M; Ubara Y
    Clin Nephrol; 2021 Jan; 95(1):54-61. PubMed ID: 33155543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.
    Magro-Checa C; Navas-Parejo Casado A; Borrego-García E; Raya-Álvarez E; Rosales-Alexander JL; Salvatierra J; Caballero-Morales T; Gómez-Morales M
    Amyloid; 2011 Dec; 18(4):235-9. PubMed ID: 21992511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.
    Hattori Y; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Sawa N; Oohashi K; Takaichi K
    Amyloid; 2012 Mar; 19(1):37-40. PubMed ID: 22260742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y; Takasugi K
    Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.
    Jung JY; Kim YB; Kim JW; Suh CH; Kim HA
    Medicine (Baltimore); 2021 Aug; 100(32):e26843. PubMed ID: 34397890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.
    Inoue D; Arima H; Kawanami C; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Mori M; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T
    Clin Rheumatol; 2010 Oct; 29(10):1195-7. PubMed ID: 20229259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition.
    Pamuk ON; Donmez S; Pamuk GE; Puyan FO; Keystone EC
    Amyloid; 2013 Dec; 20(4):245-50. PubMed ID: 24106838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
    Galmiche S; Buob D; Fellahi S; Bastard JP; Grateau G; Georgin-Lavialle S
    Joint Bone Spine; 2019 May; 86(3):397-398. PubMed ID: 30081199
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.
    Furutera N; Fukunaga N; Okita J; Suzuki T; Suenaga Y; Oyama Y; Aoki K; Fukuda A; Nakata T; Uesugi N; Daa T; Hisano S; Shibata H
    CEN Case Rep; 2021 Feb; 10(1):35-41. PubMed ID: 32715375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I; Nakayamada S; Saito K; Hanami K; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of gastrointestinal amyloidosis and hypoproteinemia improved by tocilizumab].
    Dainaka K; Isozaki Y; Kunieda K; Takayama S; Mukai R; Yamada N; Morimoto Y; Nagao Y; Oyamada H; Kawabata K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(2):245-53. PubMed ID: 26853984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
    Chantarogh S; Vilaiyuk S; Tim-Aroon T; Worawichawong S
    BMC Nephrol; 2017 May; 18(1):159. PubMed ID: 28499374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease.
    Redondo-Pachón MD; Enríquez R; Sirvent AE; Andrada E; Noguera-Pons R; Millán I; Amorós F
    Ren Fail; 2013; 35(4):547-50. PubMed ID: 23472940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
    Serelis J; Christaki S; Skopouli FN
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S169. PubMed ID: 25572486
    [No Abstract]   [Full Text] [Related]  

  • 19. Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report.
    Seneschall C; Law S; Roufosse C; Woodham S; Kousios A
    J Nephrol; 2024 Jan; ():. PubMed ID: 38206475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Kumon Y; Hirata S; Takaoka H
    Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.